[1]
2024. Impact of temporary and involuntary suppression of hydroxyurea treatment on hematological and clinical parameters in patients with sickle cell disease . Research, Society and Development. 13, 1 (Jan. 2024), e3013144727. DOI:https://doi.org/10.33448/rsd-v13i1.44727.